Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Upton

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Supportive & Palliative Care|February 26, 2015
Mind the gap: a step forward in supporting hospice-based researchAnthony Byrne, Laura Upton, Sarah Townsend
JAAD Case Reports|March 4, 2026
Multilesional pyoderma gangrenosum secondary to Hodgkin lymphomaKendall McDaniel, Simrithaa Karunakaran, Laura Upton, et al.
ACR Open Rheumatology|January 24, 2025
Recalcitrant Dermatomyositis Treated With AnifrolumabShivang Chaudhary, Meghan Baumer, Laura Upton, et al.
British Journal of Haematology|November 28, 2023
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trialMhairi Copland, Cono Ariti, Ian F Thomas, et al.
Blood Advances|October 1, 2021
Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patientsMike Dennis, Ian F Thomas, Cono Ariti, et al.
BMJ Open|September 5, 2023
HIDDEN2: Study protocol for the hospital deep vein thrombosis detection study in patients with cancer receiving palliative careTerri Kitson, Emma Osborne, Simon Noble, et al.
British Journal of Haematology|November 22, 2022
A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trialFrancis Mussai, Carmela De Santo, Paul Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2018
Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 MutationsSylvie D Freeman, Robert K Hills, Paul Virgo, et al.
ACR Open Rheumatology|November 18, 2021
Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology TraineesSu-Ann Yeoh, Kristen Young, Michael Putman, et al.
Rheumatology Advances in Practice|April 8, 2022
The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee surveyKristen Young, Su-Ann Yeoh, Michael Putman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Supportive & Palliative Care|February 26, 2015
Mind the gap: a step forward in supporting hospice-based researchAnthony Byrne, Laura Upton, Sarah Townsend
JAAD Case Reports|March 4, 2026
Multilesional pyoderma gangrenosum secondary to Hodgkin lymphomaKendall McDaniel, Simrithaa Karunakaran, Laura Upton, et al.
ACR Open Rheumatology|January 24, 2025
Recalcitrant Dermatomyositis Treated With AnifrolumabShivang Chaudhary, Meghan Baumer, Laura Upton, et al.
British Journal of Haematology|November 28, 2023
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trialMhairi Copland, Cono Ariti, Ian F Thomas, et al.
Blood Advances|October 1, 2021
Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patientsMike Dennis, Ian F Thomas, Cono Ariti, et al.
BMJ Open|September 5, 2023
HIDDEN2: Study protocol for the hospital deep vein thrombosis detection study in patients with cancer receiving palliative careTerri Kitson, Emma Osborne, Simon Noble, et al.
British Journal of Haematology|November 22, 2022
A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trialFrancis Mussai, Carmela De Santo, Paul Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2018
Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 MutationsSylvie D Freeman, Robert K Hills, Paul Virgo, et al.
ACR Open Rheumatology|November 18, 2021
Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology TraineesSu-Ann Yeoh, Kristen Young, Michael Putman, et al.
Rheumatology Advances in Practice|April 8, 2022
The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee surveyKristen Young, Su-Ann Yeoh, Michael Putman, et al.
Pageof 1